Tacrolimus 0.1% In Pseudocatalase
Product Images NDC 72934-2174

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tacrolimus 0.1% In Pseudocatalase (NDC 72934-2174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D (2174 2 End)

D (2174 2 End)
This text is a disclaimer stating that the information provided is for office use only and is not intended for resale. It also provides a website and phone number for reporting adverse drug reactions to the FDA.*
FDA Label Image

S (2174 2 Front)

S (2174 2 Front)
This is a product label for a cream containing Tacrolimus Monohydrate with the National Drug Code (NDC) 72934-2174-2 and a weight of 30 grams. It is standardized by the United States Pharmacopeia (USPO) reference publication number 196.*
FDA Label Image

D (2174 2 Middle)

D (2174 2 Middle)
Active ingredient in this medication is Tacrolimus Monohydrate. The medication also contains some inactive ingredients like Calcium Chloride, Manganese Chloride, Purified Water, and Sodium Bicarbonate. The medication is available in cream form. The text also includes a warning about the safety of opical Calcineurin in patients.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.